BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• BioForest

  LumiThera Closes Series B Round of Financing

  LumiThera raised $5.5M to support further development of its LT-300 device for the treatment for dry Age-related Macular Degeneration.

  October 31, 2017

   · 

  2 min read
• 

  Biotech Bay

  Here Are the Top 10 In Vitro Diagnostic Companies

  The companies are ranked by revenues of clinical diagnostic test instruments, reagents and supplies.

  October 31, 2017

   · 

  2 min read
• Business

  Kogenix Licenses Gene Therapy for Prevention of Age-Related Dementia and Alzheimer’s

  Boston-based Kogenix licensed the patent-pending technology used in the research.

  October 31, 2017

   · 

  2 min read
• Genetown

  VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares

  VBI also closed its concurrent registered direct offering of 7,475,410 common shares at a price of US$3.05 per share.

  October 31, 2017

   · 

  5 min read
• Business

  Aclaris Therapeutics to Announce Third Quarter 2017 Financial Results on November 7, 2017

  Management will conduct a conference call at 8:00 AM ET that day to discuss the Company’s financial results and provide a general business update.

  October 31, 2017

   · 

  1 min read
• Business

  Selecta Biosciences to Report Third Quarter 2017 Financial Results and Updated Phase 2 Data for SEL-212 on Tuesday, November 7, 2017

  t 8:30 a.m. ET that day, Selecta will host a conference call to discuss these results and provide a corporate update.

  October 31, 2017

   · 

  3 min read
• Drug Development

  Mustang Bio Reports Preclinical Data on Regional Delivery of MB-103 HER2 Chimeric Antigen Receptor Engineered T (CAR T) Cells to Target HER2+ Breast Cancer Metastasis to the Brain

  The data supports clinical development of MB-103 HER2 CAR T cell therapy.

  October 31, 2017

   · 

  4 min read
• Business

  ObsEva SA to Hold Third Quarter 2017 Financial Results and Business Update Call on November 14, 2017 and Present at Credit Suisse and Jefferies Investor Conferences in November

  Management will host an investment community conference call at 8:00 a.m. ET.

  October 31, 2017

   · 

  2 min read
• Business

  Antares Pharma to Report Third Quarter 2017 Financial and Operating Results and Host Webcast and Conference Call

  Management will host a webcast and conference call at 8:30 a.m. ET on November 7, 2017 to discuss the results.

  October 31, 2017

   · 

  5 min read
• Business

  Recro Pharma Reports Inducement Grants for New Staff - Oct. 31, 2017

  The company announced the expansion of its team through the employment of eight new employees in the areas of sales and marketing.

  October 31, 2017

   · 

  4 min read